What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Imatinib Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publish Date: Mar, 2020
Report ID: 412669
Category: Pharmaceuticals and Healthcare
Pages: 104

$3480

Market Overview

The global Imatinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Imatinib Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Imatinib Drug market has been segmented into

Tablets

Capsules

By Application, Imatinib Drug has been segmented into:

Chronic myelogenous leukemia

Gastrointestinal stromal tumors

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Imatinib Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Imatinib Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Imatinib Drug market.

The report offers in-depth assessment of the growth and other aspects of the Imatinib Drug market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Imatinib Drug Market Share Analysis

Imatinib Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Imatinib Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Imatinib Drug sales, revenue and market share for each player covered in this report.

The major players covered in Imatinib Drug are:

Novartis

Cipla Inc.

Actavis Generics

Glenmark Pharmaceuticals Ltd.

Sanofi S.A.

Sun Pharmaceuticals

Mylan Pharms Inc.

Teva Pharmaceutical Industries Ltd.

Dr. Reddy\'s Laboratories

Apotex Inc.

Among other players domestic and global, Imatinib Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Imatinib Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Imatinib Drug, with price, sales, revenue and global market share of Imatinib Drug in 2018 and 2019.

Chapter 3, the Imatinib Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Imatinib Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Imatinib Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Request Sample Request for Customization

Table of Contents

1 Market Overview

1.1 Imatinib Drug Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Imatinib Drug Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Tablets

1.2.3 Capsules

1.3 Market Analysis by Application

1.3.1 Overview: Global Imatinib Drug Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Chronic myelogenous leukemia

1.3.3 Gastrointestinal stromal tumors

1.3.4 Others

1.4 Overview of Global Imatinib Drug Market

1.4.1 Global Imatinib Drug Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Novartis Details

2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Novartis SWOT Analysis

2.1.4 Novartis Product and Services

2.1.5 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Cipla Inc.

2.2.1 Cipla Inc. Details

2.2.2 Cipla Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Cipla Inc. SWOT Analysis

2.2.4 Cipla Inc. Product and Services

2.2.5 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Actavis Generics

2.3.1 Actavis Generics Details

2.3.2 Actavis Generics Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Actavis Generics SWOT Analysis

2.3.4 Actavis Generics Product and Services

2.3.5 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Glenmark Pharmaceuticals Ltd.

2.4.1 Glenmark Pharmaceuticals Ltd. Details

2.4.2 Glenmark Pharmaceuticals Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Glenmark Pharmaceuticals Ltd. SWOT Analysis

2.4.4 Glenmark Pharmaceuticals Ltd. Product and Services

2.4.5 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Sanofi S.A.

2.5.1 Sanofi S.A. Details

2.5.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Sanofi S.A. SWOT Analysis

2.5.4 Sanofi S.A. Product and Services

2.5.5 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Sun Pharmaceuticals

2.6.1 Sun Pharmaceuticals Details

2.6.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Sun Pharmaceuticals SWOT Analysis

2.6.4 Sun Pharmaceuticals Product and Services

2.6.5 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Mylan Pharms Inc.

2.7.1 Mylan Pharms Inc. Details

2.7.2 Mylan Pharms Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Mylan Pharms Inc. SWOT Analysis

2.7.4 Mylan Pharms Inc. Product and Services

2.7.5 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Teva Pharmaceutical Industries Ltd.

2.8.1 Teva Pharmaceutical Industries Ltd. Details

2.8.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis

2.8.4 Teva Pharmaceutical Industries Ltd. Product and Services

2.8.5 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Dr. Reddy\'s Laboratories

2.9.1 Dr. Reddy\'s Laboratories Details

2.9.2 Dr. Reddy\'s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Dr. Reddy\'s Laboratories SWOT Analysis

2.9.4 Dr. Reddy\'s Laboratories Product and Services

2.9.5 Dr. Reddy\'s Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Apotex Inc.

2.10.1 Apotex Inc. Details

2.10.2 Apotex Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Apotex Inc. SWOT Analysis

2.10.4 Apotex Inc. Product and Services

2.10.5 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Imatinib Drug Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Imatinib Drug Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Imatinib Drug Manufacturer Market Share in 2019

3.3.2 Top 6 Imatinib Drug Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Imatinib Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Imatinib Drug Sales and Market Share by Regions (2015-2020)

4.1.2 Global Imatinib Drug Revenue and Market Share by Regions (2015-2020)

4.2 North America Imatinib Drug Sales and Growth Rate (2015-2020)

4.3 Europe Imatinib Drug Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Imatinib Drug Sales and Growth Rate (2015-2020)

4.5 South America Imatinib Drug Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Imatinib Drug Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Imatinib Drug Sales, Revenue and Market Share by Country

5.1.1 North America Imatinib Drug Sales and Market Share by Country (2015-2020)

5.1.2 North America Imatinib Drug Revenue and Market Share by Country (2015-2020)

5.2 United States Imatinib Drug Sales and Growth Rate (2015-2020)

5.3 Canada Imatinib Drug Sales and Growth Rate (2015-2020)

5.4 Mexico Imatinib Drug Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Imatinib Drug Sales, Revenue and Market Share by Country

6.1.1 Europe Imatinib Drug Sales and Market Share by Country (2015-2020)

6.1.2 Europe Imatinib Drug Revenue and Market Share by Country (2015-2020)

6.2 Germany Imatinib Drug Sales and Growth Rate (2015-2020)

6.3 UK Imatinib Drug Sales and Growth Rate (2015-2020)

6.4 France Imatinib Drug Sales and Growth Rate (2015-2020)

6.5 Russia Imatinib Drug Sales and Growth Rate (2015-2020)

6.6 Italy Imatinib Drug Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Imatinib Drug Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Imatinib Drug Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Imatinib Drug Revenue and Market Share by Regions (2015-2020)

7.2 China Imatinib Drug Sales and Growth Rate (2015-2020)

7.3 Japan Imatinib Drug Sales and Growth Rate (2015-2020)

7.4 Korea Imatinib Drug Sales and Growth Rate (2015-2020)

7.5 India Imatinib Drug Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Imatinib Drug Sales and Growth Rate (2015-2020)

7.7 Australia Imatinib Drug Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Imatinib Drug Sales, Revenue and Market Share by Country

8.1.1 South America Imatinib Drug Sales and Market Share by Country (2015-2020)

8.1.2 South America Imatinib Drug Revenue and Market Share by Country (2015-2020)

8.2 Brazil Imatinib Drug Sales and Growth Rate (2015-2020)

8.3 Argentina Imatinib Drug Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Imatinib Drug Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Imatinib Drug Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Imatinib Drug Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Imatinib Drug Sales and Growth Rate (2015-2020)

9.3 Turkey Imatinib Drug Sales and Growth Rate (2015-2020)

9.4 Egypt Imatinib Drug Sales and Growth Rate (2015-2020)

9.5 South Africa Imatinib Drug Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Imatinib Drug Sales and Market Share by Type (2015-2020)

10.2 Global Imatinib Drug Revenue and Market Share by Type (2015-2020)

10.3 Global Imatinib Drug Price by Type (2015-2020)

11 Global Imatinib Drug Market Segment by Application

11.1 Global Imatinib Drug Sales Market Share by Application (2015-2020)

11.2 Global Imatinib Drug Revenue Market Share by Application (2015-2020)

11.3 Global Imatinib Drug Price by Application (2015-2020)

12 Market Forecast

12.1 Global Imatinib Drug Sales, Revenue and Growth Rate (2021-2025)

12.2 Imatinib Drug Market Forecast by Regions (2021-2025)

12.2.1 North America Imatinib Drug Market Forecast (2021-2025)

12.2.2 Europe Imatinib Drug Market Forecast (2021-2025)

12.2.3 Asia-Pacific Imatinib Drug Market Forecast (2021-2025)

12.2.4 South America Imatinib Drug Market Forecast (2021-2025)

12.2.5 Middle East & Africa Imatinib Drug Market Forecast (2021-2025)

12.3 Imatinib Drug Market Forecast by Type (2021-2025)

12.3.1 Global Imatinib Drug Sales Forecast by Type (2021-2025)

12.3.2 Global Imatinib Drug Market Share Forecast by Type (2021-2025)

12.4 Imatinib Drug Market Forecast by Application (2021-2025)

12.4.1 Global Imatinib Drug Sales Forecast by Application (2021-2025)

12.4.2 Global Imatinib Drug Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Imatinib Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Imatinib Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Imatinib Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Novartis Basic Information, Manufacturing Base and Competitors

Table 8. Novartis Imatinib Drug Major Business

Table 9. Novartis Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 10. Novartis SWOT Analysis

Table 11. Novartis Imatinib Drug Product and Services

Table 12. Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Cipla Inc. Basic Information, Manufacturing Base and Competitors

Table 14. Cipla Inc. Imatinib Drug Major Business

Table 15. Cipla Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 16. Cipla Inc. SWOT Analysis

Table 17. Cipla Inc. Imatinib Drug Product and Services

Table 18. Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. Actavis Generics Basic Information, Manufacturing Base and Competitors

Table 20. Actavis Generics Imatinib Drug Major Business

Table 21. Actavis Generics Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 22. Actavis Generics SWOT Analysis

Table 23. Actavis Generics Imatinib Drug Product and Services

Table 24. Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors

Table 26. Glenmark Pharmaceuticals Ltd. Imatinib Drug Major Business

Table 27. Glenmark Pharmaceuticals Ltd. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 28. Glenmark Pharmaceuticals Ltd. SWOT Analysis

Table 29. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services

Table 30. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. Sanofi S.A. Basic Information, Manufacturing Base and Competitors

Table 32. Sanofi S.A. Imatinib Drug Major Business

Table 33. Sanofi S.A. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 34. Sanofi S.A. SWOT Analysis

Table 35. Sanofi S.A. Imatinib Drug Product and Services

Table 36. Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 38. Sun Pharmaceuticals Imatinib Drug Major Business

Table 39. Sun Pharmaceuticals Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 40. Sun Pharmaceuticals SWOT Analysis

Table 41. Sun Pharmaceuticals Imatinib Drug Product and Services

Table 42. Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors

Table 44. Mylan Pharms Inc. Imatinib Drug Major Business

Table 45. Mylan Pharms Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 46. Mylan Pharms Inc. SWOT Analysis

Table 47. Mylan Pharms Inc. Imatinib Drug Product and Services

Table 48. Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors

Table 50. Teva Pharmaceutical Industries Ltd. Imatinib Drug Major Business

Table 51. Teva Pharmaceutical Industries Ltd. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 52. Teva Pharmaceutical Industries Ltd. SWOT Analysis

Table 53. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services

Table 54. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Dr. Reddy\'s Laboratories Basic Information, Manufacturing Base and Competitors

Table 56. Dr. Reddy\'s Laboratories Imatinib Drug Major Business

Table 57. Dr. Reddy\'s Laboratories Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 58. Dr. Reddy\'s Laboratories SWOT Analysis

Table 59. Dr. Reddy\'s Laboratories Imatinib Drug Product and Services

Table 60. Dr. Reddy\'s Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. Apotex Inc. Basic Information, Manufacturing Base and Competitors

Table 62. Apotex Inc. Imatinib Drug Major Business

Table 63. Apotex Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)

Table 64. Apotex Inc. SWOT Analysis

Table 65. Apotex Inc. Imatinib Drug Product and Services

Table 66. Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Global Imatinib Drug Sales by Manufacturer (2018-2019) (K Units)

Table 68. Global Imatinib Drug Revenue by Manufacturer (2018-2019) (USD Million)

Table 69. Global Imatinib Drug Sales by Regions (2015-2020) (K Units)

Table 70. Global Imatinib Drug Sales Market Share by Regions (2015-2020)

Table 71. Global Imatinib Drug Revenue by Regions (2015-2020) (USD Million)

Table 72. North America Imatinib Drug Sales by Countries (2015-2020) (K Units)

Table 73. North America Imatinib Drug Sales Market Share by Countries (2015-2020)

Table 74. North America Imatinib Drug Revenue by Countries (2015-2020) (USD Million)

Table 75. North America Imatinib Drug Revenue Market Share by Countries (2015-2020)

Table 76. Europe Imatinib Drug Sales by Countries (2015-2020) (K Units)

Table 77. Europe Imatinib Drug Sales Market Share by Countries (2015-2020)

Table 78. Europe Imatinib Drug Revenue by Countries (2015-2020) (USD Million)

Table 79. Asia-Pacific Imatinib Drug Sales by Regions (2015-2020) (K Units)

Table 80. Asia-Pacific Imatinib Drug Sales Market Share by Regions (2015-2020)

Table 81. Asia-Pacific Imatinib Drug Revenue by Regions (2015-2020) (USD Million)

Table 82. South America Imatinib Drug Sales by Countries (2015-2020) (K Units)

Table 83. South America Imatinib Drug Sales Market Share by Countries (2015-2020)

Table 84. South America Imatinib Drug Revenue by Countries (2015-2020) (USD Million)

Table 85. South America Imatinib Drug Revenue Market Share by Countries (2015-2020)

Table 86. Middle East & Africa Imatinib Drug Sales by Countries (2015-2020) (K Units)

Table 87. Middle East & Africa Imatinib Drug Sales Market Share by Countries (2015-2020)

Table 88. Middle East & Africa Imatinib Drug Revenue by Countries (2015-2020) (USD Million)

Table 89. Middle East & Africa Imatinib Drug Revenue Market Share by Countries (2015-2020)

Table 90. Global Imatinib Drug Sales by Type (2015-2020) (K Units)

Table 91. Global Imatinib Drug Sales Share by Type (2015-2020)

Table 92. Global Imatinib Drug Revenue by Type (2015-2020) (USD Million)

Table 93. Global Imatinib Drug Revenue Share by Type (2015-2020)

Table 94. Global Imatinib Drug Sales by Application (2015-2020) (K Units)

Table 95. Global Imatinib Drug Sales Share by Application (2015-2020)

Table 96. Global Imatinib Drug Sales Forecast by Regions (2021-2025) (K Units)

Table 97. Global Imatinib Drug Market Share Forecast by Regions (2021-2025)

Table 98. Global Imatinib Drug Sales Forecast by Type (2021-2025) (K Units)

Table 99. Global Imatinib Drug Market Share Forecast by Type (2021-2025)

Table 100. Global Imatinib Drug Sales Forecast by Application (2021-2025)

Table 101. Global Imatinib Drug Market Share Forecast by Application (2021-2025)

Table 102. Direct Channel Pros & Cons

Table 103. Indirect Channel Pros & Cons

Table 104. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Imatinib Drug Picture

Figure 2. Global Sales Market Share of Imatinib Drug by Type in 2019

Figure 3. Tablets Picture

Figure 4. Capsules Picture

Figure 5. Imatinib Drug Sales Market Share by Application in 2018

Figure 6. Chronic myelogenous leukemia Picture

Figure 7. Gastrointestinal stromal tumors Picture

Figure 8. Others Picture

Figure 9. Global Imatinib Drug Market Status and Outlook (2015-2025) (USD Million)

Figure 10. United States Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 11. Canada Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Mexico Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Germany Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 14. France Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 15. UK Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Russia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Italy Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 18. China Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Japan Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Korea Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 21. India Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Southeast Asia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Australia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 24. Brazil Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Egypt Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Saudi Arabia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 27. South Africa Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Turkey Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Global Imatinib Drug Sales Market Share by Manufacturer in 2019

Figure 30. Global Imatinib Drug Revenue Market Share by Manufacturer in 2019

Figure 31. Top 3 Imatinib Drug Manufacturer (Revenue) Market Share in 2019

Figure 32. Top 6 Imatinib Drug Manufacturer (Revenue) Market Share in 2019

Figure 33. Key Manufacturer Market Share Trend

Figure 34. Global Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 35. Global Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 36. Global Imatinib Drug Revenue Market Share by Regions (2015-2020)

Figure 37. Global Imatinib Drug Revenue Market Share by Regions in 2018

Figure 38. North America Imatinib Drug Sales and Growth Rate (2015-2020)

Figure 39. Europe Imatinib Drug Sales and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Imatinib Drug Sales and Growth Rate (2015-2020)

Figure 41. South America Imatinib Drug Sales and Growth Rate (2015-2020)

Figure 42. Middle East & Africa Imatinib Drug Sales and Growth Rate (2015-2020)

Figure 43. North America Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 44. North America Imatinib Drug Sales Market Share by Countries (2015-2020)

Figure 45. North America Imatinib Drug Sales Market Share by Countries in 2018

Figure 46. North America Imatinib Drug Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 47. North America Imatinib Drug Revenue Market Share by Countries in 2018

Figure 48. United States Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 49. Canada Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 50. Mexico Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 51. Europe Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 52. Europe Imatinib Drug Revenue Market Share by Countries (2015-2020)

Figure 53. Europe Imatinib Drug Revenue Market Share by Countries in 2019

Figure 54. Germany Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 55. UK Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 56. France Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 57. Russia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 58. Italy Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 59. Asia-Pacific Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 60. Asia-Pacific Imatinib Drug Sales Market Share by Regions 2019

Figure 61. Asia-Pacific Imatinib Drug Revenue Market Share by Regions 2019

Figure 62. China Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 63. Japan Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 64. Korea Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 65. India Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 66. Southeast Asia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 67. South America Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 68. South America Imatinib Drug Sales Market Share by Countries in 2019

Figure 69. South America Imatinib Drug Revenue Market Share by Countries in 2019

Figure 70. Brazil Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 71. Argentina Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 72. Middle East and Africa Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 73. Middle East and Africa Imatinib Drug Sales Market Share by Countries in 2019

Figure 74. Middle East and Africa Imatinib Drug Revenue Market Share by Countries (2015-2020)

Figure 75. Middle East and Africa Imatinib Drug Revenue Market Share by Countries in 2019

Figure 76. Saudi Arabia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 77. Egypt Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 78. Turkey Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 79. South Africa Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 80. Global Imatinib Drug Sales and Growth Rate (2021-2025) (K Units)

Figure 81. Global Imatinib Drug Revenue and Growth Rate (2021-2025) (USD Million)

Figure 82. North America Sales Imatinib Drug Market Forecast (2021-2025) (K Units)

Figure 83. Europe Sales Imatinib Drug Market Forecast (2021-2025) (K Units)

Figure 84. Asia-Pacific Sales Imatinib Drug Market Forecast (2021-2025) (K Units)

Figure 85. South America Sales Imatinib Drug Market Forecast (2021-2025) (K Units)

Figure 86. Middle East & Africa Sales Imatinib Drug Market Forecast (2021-2025) (K Units)

Figure 87. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!